UK – Ledaga recommended by NICE for rare type of lymphoma

The National Institute for Health and Care Excellence (NICE) has recommended Recordati Rare Diseases and Helsinn Healthcare’s Ledaga for a type of lymphoma that affects the skin.

Ledaga (chlormethine gel) is recommended for use on the NHS to treat early-stage mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL). It is used as a topical ointment, applied as a thin layer once daily, to relieve symptoms of the disease.

MF-CTCL is a form of non-Hodgkin’s lymphoma that affects the skin, causing itchy and painful red patches or lesions…